J&J lowers price of Elan stake (Dealscape

Irish drugmaker Elan Corp. plc has revised its agreement with healthcare giant Johnson & Johnson and will get $885 million for an 18.4% stake in the company -- $115 million less than the original price.

The new agreement resolves a dispute between Elan and its U.S. partner, Biogen Idec Inc., with which it sells multiple sclerosis drug Tysabri in a 50-50 partnership.

This is a free content preview. Subscribers enjoy access to all stories in full as well as second-to-none market intelligence.

Dig deeper, with Pipeline.

606 company pages related to Pharmaceuticals
138 in-depth transaction records for Johnson & Johnson
107 in-depth reports of Auctions in the Healthcare sector from 2009
21 in-depth transaction records for Elan Corp. plc
10 years of news and analysis archives from the voice of The Deal Economy

Most searched keywords

Deutsche Bank
Agrium Inc.
Revolution Money
Tandberg ASA
Birds Eye
Skadden Arps
Natco
UBS AG
Cerberus
Terra Industries

Forward-looking intelligence allows you time to act. View this video on our restructuring content to see how you can benefit from our expertise.
NOT A SUBSCRIBER? J&J lowers price of Elan stake Posted on September 15, 2009 4:49 PM Irish drugmaker Elan Corp. plc has revised its agreement with healthcare giant Johnson & Johnson and will get $885 million for an 18.4% stake in the company -- $115 million less than the original price. The new agreement resolves a dispute between Elan and its U.S. partner, Biogen Idec Inc., with which it sells multiple sclerosis drug Tysabri in a 50-50 partnership. This is a free content preview. Subscribers enjoy access to all stories in full as well as second-to-none market intelligence. Dig deeper, with Pipeline. 606 company pages related to Pharmaceuticals 138 in-depth transaction records for Johnson & Johnson 107 in-depth reports of Auctions in the Healthcare sector from 2009 21 in-depth transaction records for Elan Corp. plc 10 years of news and analysis archives from the voice of The Deal Economy Most searched keywords Deutsche Bank Agrium Inc. Revolution Money Tandberg ASA Birds Eye Skadden Arps Natco UBS AG Cerberus Terra Industries		EXISTING USERS Username Password Forget your password? Missing a product?

Sales Contact Michael Crosby mcrosby@thedeal.com 212.313.9325	Media Contact Martha Brown mbrown@thedeal.com 212.313.9218
Signing in signifies that you agree to our terms and conditions. View our privacy policy.